$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Ferroportin antibodies and methods of use 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07K-016/28
  • G01N-033/68
  • G01N-033/90
  • A61K-038/18
  • A61K-039/395
  • A61K-039/00
출원번호 US-0866105 (2015-09-25)
등록번호 US-9688759 (2017-06-27)
발명자 / 주소
  • Arvedson, Tara
  • Dyas, Gregory
  • Rottman, James B.
  • Sasu, Barbra
  • Bi, Xiao-juan
  • Lee, Grace Ki Jeong
  • Sheng, Jackie Z.
출원인 / 주소
  • Amgen, Inc.
대리인 / 주소
    Bugaisky, Lawrence
인용정보 피인용 횟수 : 0  인용 특허 : 76

초록

Compositions for treating disorders of iron homeostasis are provided. More particularly, anti-ferroportin antibodies, compositions containing such antibodies, corresponding nucleic acids, vectors and host cells, and methods of making such antibodies are provided.

대표청구항

1. A method for increasing hemoglobin or hematocrit in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an isolated monoclonal antibody that binds to an extracellular domain of human ferroportin and preserves ferroportin activity, wherein the mo

이 특허에 인용된 특허 (76)

  1. Johnson Dana L. ; Zivin Robert A., Agonist peptide dimers.
  2. Leung, Donmienne Doen Mun; Luan, Peng; Manetta, Joseph Vincent; Tang, Ying; Witcher, Derrick Ryan, Anti-ferroportin 1 monoclonal antibodies and uses thereof.
  3. Leung, Donmienne Doen Mun; Luan, Peng; Manetta, Joseph Vincent; Tang, Ying; Witcher, Derrick Ryan, Anti-ferroportin 1 monoclonal antibodies and uses thereof.
  4. Lam Xanthe M. ; Oeswein James Q. ; Ongpipattanakul Boonsri,THX ; Shahrokh Zahra ; Wang Sharon X. ; Weissburg Robert P. ; Wong Rita L., Antibody formulation.
  5. Rubenstein Kenneth Edward (Palo Alto CA) Leute Richard K. (Sunnyvale CA), Antibody steric hindrance immunoassay with two antibodies.
  6. Miller Lois K. (Athens GA), Baculovirus expression vectors.
  7. Davis Paul James,GBX ; van der Logt Cornelis Paul Erik,GBX ; Verhoeyen Martine Elisa,GBX ; Wilson Steve,GBX, Bifunctional or bivalent antibody fragment analogue.
  8. Iwashita Yuji (Kawasaki JPX) Ajisaka Katsumi (Yokohama JPX), Blood substitute containing modified hemoglobin.
  9. Adair John Robert,GBX ; Bodmer Mark William,GBX ; Mountain Andrew,GBX ; Owens Raymond John,GBX, CDR grafted anti-CEA antibodies and their production.
  10. Darfler Frederick J. (Derwood MD), Cell culture medium with antioxidant.
  11. Gao Dayong ; Critser John K., Cell-type-specific methods and devices for the low temperature preservation of the cells of an animal species.
  12. Seidman Jonathan G. (Milton MA) Jakobovits Aya (Menlo Park CA), Cells homozygous for disrupted target loci.
  13. Kinstler, Olaf; Gegg, Colin; Freeman, Aimee; Boone, Thomas, Chemically modified novel erythropoietin stimulating protein compositions and methods.
  14. Nakagawa Yasushi (Kawanishi JPX) Ito Takashi (Osaka JPX), Chemically modified protein with polyethyleneglycol.
  15. Wrighton Nicholas C. ; Dower William J. ; Chang Ray S. ; Kashyap Arun K. ; Jolliffe Linda K. ; Johnson Dana ; Mulcahy Linda, Compounds and peptides that bind to the erythropoietin receptor.
  16. Mitra Gautam (Kensington CA), Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer.
  17. Lin Fu-Kuen (Thousand Oaks CA), DNA sequences encoding erythropoietin.
  18. Ladner Robert C. (Ijamsville MD) Guterman Sonia K. (Belmont MA) Roberts Bruce L. (Milford MA) Markland William (Milford MA) Ley Arthur C. (Newton MA) Kent Rachel B. (Boxborough MA), Directed evolution of novel binding proteins.
  19. Uzgiris Egidijus E. (Schenectady NY), Electrophoretic method of detecting antigen-antibody reaction.
  20. Gordon Julian (Arlesheim CHX) Staehelin Theophil (Arlesheim CHX) Towbin Harry (Allschwil CHX), Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays.
  21. Lerner Richard (La Jolla CA) Janda Kim (San Diego CA) Brenner Sydney (Cambridge GB2), Encoded combinatorial chemical libraries.
  22. Bailon, Pascal Sebastian, Erythropoietin conjugates.
  23. Strickland Thomas Wayne, Erythropoietin isoforms.
  24. Lai Por-Hsiung (Westlake Village CA) Strickland Thomas W. (Camarillo CA), Erythropoietin purification.
  25. Sun, Lee-Hwei K.; Sun, Bill N. C.; Sun, Cecily R. Y., Fc fusion proteins of human erythropoietin with increased biological activities.
  26. Sun,Lee Hwei K.; Sun,Bill N. C.; Sun,Cecily R. Y., Fc fusion proteins of human erythropoietin with increased biological activities.
  27. Arvedson, Tara; Dyas, Gregory; Rottman, James B.; Sasu, Barbra; Bi, Xiao-juan; Lee, Grace Ki Jeong; Sheng, Jackie Z., Ferroportin antibodies and methods of use.
  28. Zon,Leonard I.; Donovan,Adriana, Ferroportin1 nucleic acids and proteins.
  29. Jorgenson Ralph C. (Mercer Island WA) Yee Sinclair S. (Seattle WA), Fiber optic sensor and methods and apparatus relating thereto.
  30. Ullman Edwin F. (Atherton CA) Schwarzberg Moshe (Palo Alto CA), Fluorescence quenching with immunological pairs in immunoassays.
  31. Elliott,Steven G.; Byrne,Thomas E., Glycosylation analogs of erythropoietin.
  32. Iwasaki Keiji (Kawasaki JPX) Iwashita Yuji (Kawasaki JPX) Okami Taketoshi (Yokohama JPX), Hemoglobin combined with a poly(alkylene oxide).
  33. Kucherlapati Raju ; Jakobovits Aya ; Brenner Daniel G. ; Capon Daniel J. ; Klapholz Sue, Human antibodies derived from immunized xenomice.
  34. Queen Cary L. (Los Altos CA) Co Man Sung (Cupertino CA) Schneider William P. (Mountain View CA) Landolfi Nicholas F. (Milpitas CA) Coelingh Kathleen L. (San Francisco CA) Selick Harold E. (Belmont CA, Humanized immunoglobulins.
  35. Queen Cary L. (Los Altos CA) Selick Harold E. (Belmont CA), Humanized immunoglobulins.
  36. Queen Cary L. (Los Altos CA) Selick Harold E. (Belmont CA), Humanized immunoglobulins.
  37. David Gary S. (La Jolla CA) Greene Howard E. (Carlsbad CA), Immunometric assays using monoclonal antibodies.
  38. Goldenberg David M., Immunotherapy of B-cell malignancies using anti-CD22 antibodies.
  39. Mattheakis Larry C. ; Dower William J., In vitro peptide and antibody display libraries.
  40. Goroff Diana K. (Chevy Chase MD), In-vitro method for producing antigen-specific human monoclonal antibodies.
  41. Hiratani Hajime (Sennan JPX), Long-acting composition.
  42. Center David M. ; Cruikshank William W. ; Kornfeld Hardy, Lymphocyte chemoattractant factor and uses thereof.
  43. Mather Jennie P. (Millbrae CA) Tsao Mary C. (Burlingame CA), Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins.
  44. Kucherlapati Raju ; Jakobovits Aya, Method of making transgenic mice lacking endogenous heavy chains.
  45. Borrebaeck Carl (Lund SEX) Danielsson Lena (Lund SEX) Moller Susanna (Lund SEX), Method of producing human monoclonal antibodies and kit therefor.
  46. Wrighton Nicholas C. ; Dower William J. ; Chang Ray S. ; Kashyap Arun K., Methods of administering peptides that bind to the erythropoietin receptor.
  47. Studnicka Gary M. ; Little ; II Roger G. ; Fishwild Dianne M. ; Kohn Fred R., Modified antibody variable domains.
  48. Davis Frank F. (19 Farmingdale Rd. East Brunswick NJ 08816) Van Es Theodorus (313 Overbrook Rd. Piscataway NJ 08854) Palczuk Nicholas C. (45 W. Franklin St. Bound Brook NJ 08805), Non-immunogenic polypeptides.
  49. Schatz Peter J. (Mountain View CA) Cull Millard G. (Oakland CA) Miller Jeff F. (Los Angeles CA) Stemmer Willem P. C. (Los Gatos CA), Peptide library and screening method.
  50. Schatz Peter J. (Mountain View CA) Stemmer Willem P. C. (Menlo Park CA), Peptide library and screening method.
  51. Schatz Peter J. ; Cull Millard G. ; Miller Jeff F. ; Stemmer Willem Peter Christiaan ; Gates Christian M., Peptide library and screening method.
  52. Dower William J. (Menlo Park CA) Cwirla Steven E. (Palo Alto CA) Barrett Ronald W. (Sunnyvale CA), Peptide library and screening systems.
  53. Holmes,Christopher P.; Yin,Qun; Lalonde,Guy; Schatz,Peter J.; Tumelty,David; Palani,Balu; Zemede,Genet, Peptides that bind to the erythropoietin receptor.
  54. Wrighton Nicholas C. ; Dower William J. ; Chang Ray S. ; Kashyap Arun K., Peptides that bind to the erythropoietin receptor.
  55. Shimizu Kimihiro (Yoshikawa JPX) Nakahara Tsuguji (Tokyo JPX) Kinoshita Taketoshi (Koshigaya JPX) Takatsuka Jun (Kawasaki JPX) Igarashi Michiko (Musashino JPX), Plasminogen activator derivatives.
  56. Shimizu Kimihiro (Yoshikawa-danchi 4-16-102 Yoshikawa-machi ; Kitakatsushika-gun ; Saitama-ken JPX) Nakahara Tsuguji (6-21-6 Megurohonmachi ; Meguro-ku ; Tokyo JPX) Kinoshita Taketoshi (Satsuki-so ; , Plasminogen activator derivatives.
  57. Surani Azim M. (Cambridge GB3) Neuberger Michael S. (Cambridge GB3) Bruggemann Marianne (Cambridge GB3), Production of antibodies from transgenic animals.
  58. Hoogenboom Hendricus R. J. M. (Cambridge GBX) Baier Michael (Frankfurt DEX) Jespers Laurent S. A. T. (Tervuren BEX) Winter Gregory P. (Cambridge GBX), Production of chimeric antibodies - a combinatorial approach.
  59. Lin Fu-Kuen, Production of erthropoietin.
  60. Lin Fu-Kuen, Production of erythropoietin.
  61. Lin Fu-Kuen (Thousand Oaks CA), Production of erythropoietin.
  62. Lin Fu-Kuen (Thousand Oaks CA), Production of erythropoietin.
  63. Lin Fu-Kuen (Thousand Oaks CA), Production of erythropoietin.
  64. Anne Stern DE; Michael Brandt DE; Konrad Honold DE; Johannes Auer DE; Hans Koll DE, Production of erythropoietin by endogenous gene activation.
  65. Lin Fu-Kuen (Thousand Oaks CA), Production of recombinant erythropoietin.
  66. Cleveland William L. (New York NY) Erlanger Bernard F. (Whitestone NY), Protein-free culture medium.
  67. Piasio ; Roger N. ; Ryan ; James W. ; Woiszwillo ; James E., Reverse sandwich immunoassay.
  68. Cartaya Oscar A. (125 Pleasant St. ; Apt. #401 Brookline MA 02146), Serum-free cell culture media.
  69. Baker, Paul E., Serum-free cell culture medium and process for making same.
  70. Kumar Sudhir (18901 Springfield Flossmoor IL 60422), Serum-free, synthetic, completely chemically defined tissue culture media.
  71. Katre Nandini (El Cerrito CA) Knauf Michael J. (Oakland CA), Solubilization of proteins for pharmaceutical compositions using polymer conjugation.
  72. Connolly Peter J. ; Bandurco Victor T. ; Wetter Steven K. ; Johnson Sigmond ; Bussolari Jacqueline ; Murray William V., Substituted amino acids as erythropoietin mimetics.
  73. Connolly, Peter J.; Bandurco, Victor T.; Wetter, Steven K.; Johnson, Sigmond; Bussolari, Jacqueline; Murray, William V., Substituted amino acids as erythropoietin mimetics.
  74. Segal David M. (Rockville MD) Perez Pilar (Bethesda MD), Target specific cross-linked heteroantibodies.
  75. Krimpenfort Paulus J. A. (Amsterdam NLX) Berns Antonius J. M. (Spaarndam NLX), Transgenic mice depleted in a mature lymphocytic cell-type.
  76. Miles Laughton E. M. (Stanford CA), Universal reagent 2-site immunoradiometric assay using labelled anti (IgG).
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로